News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
195,457 Results
Type
Article (14631)
Company Profile (32)
Press Release (180794)
Section
Business (55546)
Career Advice (687)
Deals (9852)
Drug Delivery (31)
Drug Development (29599)
Employer Resources (71)
FDA (5006)
Job Trends (4328)
News (100786)
Policy (8529)
Tag
Academia (1324)
Alliances (16167)
Alzheimer's disease (449)
Approvals (5006)
Artificial intelligence (58)
Bankruptcy (79)
Best Places to Work (3543)
Breast cancer (72)
Cancer (498)
Cardiovascular disease (46)
Career advice (575)
CAR-T (46)
Cell therapy (113)
Clinical research (24760)
Collaboration (183)
COVID-19 (1225)
C-suite (45)
Data (601)
Diabetes (79)
Diagnostics (1925)
Drug discovery (39)
Earnings (15429)
Employer resources (64)
Events (23115)
Executive appointments (179)
FDA (5280)
Funding (206)
Gene therapy (76)
GLP-1 (256)
Government (1368)
Healthcare (5802)
Infectious disease (1275)
Inflammatory bowel disease (54)
Interviews (112)
IPO (3715)
Job creations (919)
Job search strategy (512)
Layoffs (88)
Legal (1628)
Lung cancer (58)
Manufacturing (72)
Medical device (3531)
Medtech (3533)
Mergers & acquisitions (6256)
Metabolic disorders (189)
Neuroscience (599)
NextGen: Class of 2025 (2175)
Non-profit (1866)
Northern California (464)
Obesity (89)
Opinion (52)
Parkinson's disease (45)
People (19816)
Phase I (5755)
Phase II (10684)
Phase III (9853)
Pipeline (204)
Policy (44)
Postmarket research (1169)
Preclinical (2181)
Press Release (48)
Radiopharmaceuticals (65)
Rare diseases (93)
Real estate (1675)
Regulatory (6122)
Research institute (1149)
Resumes & cover letters (90)
Series A (45)
Southern California (440)
Startups (1362)
United States (4608)
Vaccines (298)
Weight loss (64)
Date
Today (27)
Last 7 days (173)
Last 30 days (706)
Last 365 days (9170)
2025 (1452)
2024 (9292)
2023 (10673)
2022 (14468)
2021 (16167)
2020 (15900)
2019 (14939)
2018 (11613)
2017 (10776)
2016 (10323)
2015 (12173)
2014 (8381)
2013 (6750)
2012 (7010)
2011 (7525)
2010 (6585)
Location
Africa (281)
Asia (13544)
Australia (2577)
California (1099)
Canada (371)
China (135)
Colorado (53)
Connecticut (49)
Europe (35210)
Florida (155)
Georgia (97)
Illinois (137)
Indiana (73)
Japan (56)
Maryland (211)
Massachusetts (764)
Minnesota (122)
New Jersey (395)
New York (438)
North Carolina (187)
Northern California (464)
Ohio (42)
Pennsylvania (275)
South America (405)
Southern California (440)
Texas (138)
Washington State (152)
195,457 Results for "enigma biomedical group".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Enigma Biomedical USA Announces Formation of Scientific Advisory Board
December 3, 2024
·
3 min read
Press Releases
Neuraly and Enigma Biomedical USA announce a Research License and Commercialization Option Agreement for PET Imaging Biomarker, PMI04
January 17, 2025
·
4 min read
Business
Enigma Biomedical Group - USA Signs License Agreement with AbbVie for Novel 4R Tau PET Imaging Biomarkers
Enigma Biomedical Group - USA (EBG-USA) today announced it has signed an exclusive license and option agreement with AbbVie for the development and potential commercialization of AbbVie’s next-generation F18 PET imaging biomarkers to assess the presence of four-repeat (4R) tau protein in patients with suspected neurodegenerative disease.
January 18, 2024
·
2 min read
Press Releases
Enigma Biomedical USA and the University of Wisconsin–Madison announce Formation of a Partnership to Advance Development of Next-Generation Imaging and Fluid Biomarkers for Improved Understanding and Management of Neurodegenerative Diseases
January 16, 2025
·
3 min read
Business
Enigma Biomedical - USA Announces Appointment of Hartmuth Kolb, PhD as Chief Scientific Officer
Enigma Biomedical USA announced the appointment of Hartmuth Kolb, PhD as Chief Science Officer. Dr. Kolb’s passion for innovation and scientific rigor has driven his extensive career and broad recognition.
February 13, 2024
·
2 min read
Press Releases
European Wellness Biomedical Group Announces New Klotho Research Initiative Led by Prof. Mike Chan
December 20, 2024
·
4 min read
Press Releases
Psyence Biomedical Announces Closing of Previously Announced Acquisition of Psyence Group’s Stake in PsyLabs
October 31, 2024
·
8 min read
Press Releases
European Wellness Biomedical Group, Headed by Prof. Mike Chan, Release New Study on Bioregenerative Blueprint for Athletic Longevity
November 26, 2024
·
6 min read
Press Releases
European Wellness Biomedical Group Unveils State-of-the-Art Premier Centre in Kota Kinabalu, Sabah
October 10, 2024
·
7 min read
Press Releases
Pharming Group to participate in March 2025 investor conference
February 28, 2025
·
1 min read
1 of 19,546
Next
